Takeda Pharmaceutical Ltd ADR (NY: TAK )Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Current Report: Takeda Pharmaceutical (TAK)
January 23, 2023
HUTCHMED Out Licenses Fruquintinib To Takeda Outside China
January 23, 2023
A Bullish Sign Appears On Takeda Pharmaceutical's Chart
December 28, 2022
Takeda To Add Mid-Stage Autoimmune Disease Candidate For $4B
December 13, 2022
7 Sorry Dividend Stocks to Sell in February Before It’s Too Late
January 30, 2023
Takeda Named Global Top Employer for Sixth Consecutive Year
January 16, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|